MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PLX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Protalix BioTherapeutics (PLX) Ownership - Who owns Protalix BioTherapeutics?

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
226
Web
https://www.protalix.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
159.53M
P/E Ratio
10.42
Total Cash
51.08M
Projected Growth
N/A
Total Debt
8.48M
Revenue
76.38M
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash/Share
0.63
Total Debt/Equity
N/A
Revenue/Share
0.95 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PLX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PLX
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
226
Web
https://www.protalix.com